What constitutes adequate and cost-effective cardiac screening prior to vigorous activity for collegiate athletes and older adults?

Dialogues in Cardiovascular Medicine

Volumn 7, Issue 3, 2002, Pages 165-171

  Pelliccia, Antonio ^a  

^a Italian National Olympic Committee   (Italy)

Author keywords

Athletic heart syndrome; Echocardiogram; Electrocardiogram; Sudden cardiac death

Indexed keywords

ANAMNESIS; ARTICLE; ATHLETE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EXERCISE TEST; GENETIC SCREENING; HEART DILATATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL SOCIETY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; SCREENING TEST; SPORT; SUDDEN DEATH;

EID: 0038299315     PISSN: 12729949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Burke AP, Farb V, Virmani R, et al. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J. 1991;121:568-575.
2. Maron BJ, Shirani J, Poliac LC. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996;276:199-204.
3. Taylor AJ, Rogan KM, Virmani R. Sudden cardiac death associated with congenital coronary artery anomalies. J Am Coll Cardiol. 1992;20:640-647.
4. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493-501.
5. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133.
6. Corrado D, Thiene G, Nava A, et al. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990;89:588-596.
7. Thompson PD, Funk EJ, Carleton RA, et al. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA. 1982;247:2535-2538.
8. Virmani R, Robinowitz M, McAllister HA Jr. Nontraumatic death in joggers: a series of 30 patients at autopsy. Am J Med. 1982;72:874-882.
9. Maron BJ, Kogan J, Proschan MA, et al. Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1994;23:1405-1409.
10. Maron BJ, Mitchell JH. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 1994;24:845-899.
11. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals for the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Disease in the Young) American Heart Association. Circulation. 1996;94:850-856.
12. Maron BJ, Wolfson JK, Cirò E, et al. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol. 1983;51:189-194.
13. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J. 1994;71:215-218.
14. Priori SG, Barhanin J, Hauer RNW, et al. Genetic and molecular basis of cardiac arrhythmias. Impact on clinical management. Eur Heart J. 1999;20:174-195.
15. Huston P, Puffer JC, MacMillan Rodney W. The athletic heart syndrome. N Engl J Med. 1985;315:24-32.
16. Lichtman J, O'Rourke RA, Klein A, Karliner JS. Electrocardiogram of the athlete: alterations simulating those of organic heart disease. Arch Intern Med. 1973;132:763-770.
17. Zehender M, Meinertz T, Keul J, Just H. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J. 1990;119:1378-1391.
18. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation. 2000;102:278-284.
19. Pelliccia A, DeLuca R, Di Paolo FM, Spataro A, Maron BJ. The long-term clinical significance of distinctly abnormal 12-lead ECG patterns highly suggestive of hypertrophic cardiomyopathy in trained athletes (abstract). Circulation. 2000;102(suppl II):II420.
20. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspective from the 30-year Italian experience. Am J Cardiol. 1995;75:827-829.
21. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364-369.
22. Fuller CM, McNulty CMD, Spring DA, et al. Prospective screening of 5,615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc. 1997;9:1131-1138.
23. Maron BJ, Araujo CG, Thompson PD, et al. Recommendations for preparticipation screening and the assessment of cardiovascular diseases in masters athletes. An advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on exercise, cardiac rehabilitation, and prevention. Circulation. 2001;103:327-334.
24. Rautaharju PM, Prineas RJ, Eifler WJ, et al. Prognostic value of exercise electrocardiogram in men at high risk of future coronary artery disease: the Multiple Risk Factor Intervention Trial experience. N Engl J Med. 1987;317:1055-1059.
25. Bruce RA, DeRouen TA, Hossack KF. Value of maximal exercise tests in risk assessment of primary coronary artery disease events in healthy men: five years' experience of the Seattle Heart Watch Study. Am J Cardiol. 1980;46:371-378.